Microsatellite Instability Testing
The latest news on microsatellite instability testing.
MD Anderson Researchers Explore Neoadjuvant Keytruda in MSI-high Solid Tumors
The study presented at the ESMO Congress also suggested that ctDNA testing may predict which patients should have surgery to remove their tumors and those who can do without it.
Based on insights gleaned from earlier trials of its Granite and Slate neoantigen immunotherapies, the company is improving the design of its vaccines and homing in on best responders.
Merck Nets Two Keytruda Approvals in Japan for TNBC, Colon Cancer
Japanese regulators approved pembrolizumab for PD-L1-positive triple-negative breast cancer and microsatellite instability-high colorectal cancer patients.Â
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.
FDA Grants Full Approval to Merck, Eisai's Keytruda, Lenvima Combo in Endometrial Cancer
Based on results from the Phase III Keynote-775 trial, the agency converted its prior accelerated approval of the regimen to full approval.